Insider trades › Bristol Myers Squibb › Cari Gallman
Cari Gallman: Bristol Myers Squibb stock transactions
Cari Gallman (EVP, General Counsel at Bristol Myers Squibb) reported 4 transactions in BMY stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: Gallman Cari.
$0open-market sales (0 shares)
$0open-market purchases (0 shares)
2026-10-02most recent transaction
Transactions
| Date | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Oct 2, 2026 | Option or RSU exercise | 4,559 | — | — | Form 4 ↗ |
| Oct 2, 2026 | Shares withheld for tax | 2,332 | $61.15 | — | Form 4 ↗ |
| Aug 1, 2026 | Option or RSU exercise | 1,061 | — | — | Form 4 ↗ |
| Aug 1, 2026 | Shares withheld for tax | 543 | $65.31 | — | Form 4 ↗ |
Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.